BIIB
Biogen Inc.
Stock
$222.82−3.06 (−1.35%)Close Oct 1, 2026
| Long-term debt (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $7.3B | +16.0% | −3.3% | −0.4% |
| Long-term debt (Q2 2026) | $7.3B |
|---|---|
| YoY | +16.0% |
| 5-year CAGR | −3.3% |
| 10-year CAGR | −0.4% |
Long-term debt
| Period | Long-term debt | YoY |
|---|---|---|
| 2025 | $6.3B | +38.3% |
| 2024 | $4.5B | −33.0% |
| 2023 | $6.8B | +8.1% |
| 2022 | $6.3B | +0.1% |
| 2021 | $6.3B | −15.5% |
| 2020 | $7.4B | +66.5% |
| 2019 | $4.5B | −24.9% |
| 2018 | $5.9B | 0.0% |
| 2017 | $5.9B | −8.9% |
| 2016 | $6.5B | −0.1% |
| 2015 | $6.5B | +1,023.8% |
| 2014 | $580M | −2.0% |
| 2013 | $592M | −13.8% |
| 2012 | $687M | −32.9% |
| 2011 | $1.0B | −1.1% |
| 2010 | $1.0B | — |